<%= '<' %>script src="/polyfill.dll.js" <%= '>' %> <%= '<' %>/script <%= '>' %> <%= '<' %>script src="/vendor.dll.js" <%= '>' %> <%= '<' %>/script <%= '>' %>

Assisted Hatching

Laser Assisted Hatching

Assisted hatching facilitates in creating a hole in or thinning the zona pellucida, helping the embryo in the hatching process. The procedure is performed just before embryo transfer and has shown to significantly improve implantation rates. It is a safe procedure and is highly recommended for frozen embryos where the zona is hardened due to exposure to cryoprotectants and extremely low temperatures.

About Service
FAQ's
Who will benefit from Assisted Laser Hatching?

Patients with day 3 embryos having thick zona pellucida.
Patients with previous IVF/ICSI failures.
Hard/ thick zona pellucida has been observed commonly in women older than 37.
Patients with a high Follicle Stimulating Hormone (FSH) level or those that require a high dose of gonadotropins due to poor ovarian response.

How is assisted hatching performed?

At Rainbow Hospitals, the latest technology called as AssistedLaser Hatching is used to provide the safest, fastest and the most effective results. The embryo is subjected to very few low intensity pulses of laser and the zonapellucida is either made thin or a small hole is made. The cells inside the embryo (blastomeres) are carefully protected from the direction of the laser. This procedure takes only a few seconds when done by experts.

What are the risks of using laser?

Since the laser is targeted at the outer shell only carefully avoiding the blastomeres (inner cells), this procedure is quite safe.

Is it harmful to the embryo in any way?

ALH assists in the implantation of the embryo. No known genetic or physical anomalies have been reported in offspring that resulted from embryos that were subjected to laser hatching,

Who will benefit from Assisted Laser Hatching?

1.       Patients with day 3 embryos having thick zona pellucida.
2.       Patients with previous IVF/ICSI failures.
3.       Hard/ thick zona pellucida has been observed commonly in women older than 37.
4.       Patients with a high Follicle Stimulating Hormone (FSH) level or those that require a high dose of gonadotropins due to poor ovarian response.

SUBSCRIBE NOW FOR Newsletter